{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:09:24Z","timestamp":1790251764451,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jaccas.2026.107006","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:33:50Z","timestamp":1771590830000},"page":"107006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atrial Septal Defect Surgical Closure Following Trametinib Utilization in Noonan Syndrome\u2013Associated Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"31","author":[{"given":"Camden","family":"Hebson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Escott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Beltran-Ale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Andelfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Linscott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaccas.2026.107006_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.37603","article-title":"Multidisciplinary treatment of patients with Noonan syndrome: a consensus statement","volume":"8","author":"Stagi","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jaccas.2026.107006_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00246-025-03812-w","article-title":"Heart transplantation outcomes in pediatric patients with Noonan syndrome: an institutional case series","volume":"47","author":"Andreola","year":"2025","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"10.1016\/j.jaccas.2026.107006_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacbts.2024.10.002","article-title":"Impact of MEK inhibition on childhood RASopathy-associated hypertrophic cardiomyopathy","volume":"10","author":"Wolf","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccas.2026.107006_bib4","first-page":"1","article-title":"Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies","volume":"6","author":"Petrini","year":"2025","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"10.1016\/j.jaccas.2026.107006_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.71505","article-title":"First report of trametinib-nintedanib combination in KRAS G12D-mutated pancreatic cancer","volume":"13","author":"Zhao","year":"2025","journal-title":"Clin Case Rep"},{"issue":"12","key":"10.1016\/j.jaccas.2026.107006_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","article-title":"Dabrafenib plus Trametinib in pediatric glioma with BRAF V600 mutations","volume":"389","author":"Bouffet","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jaccas.2026.107006_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/1078-0432.CCR-23-1503","article-title":"FDA approval summary: dabrafenib in combination with Trametinib for BRAFV600E mutation\u2013 positive low-grade glioma","volume":"30","author":"Barbato","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"28","key":"10.1016\/j.jaccas.2026.107006_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf4766","article-title":"RASdependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy","volume":"9","author":"Cuevas-Navarro","year":"2023","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.jaccas.2026.107006_bib9","first-page":"789","article-title":"MEK inhibition for RASopathy-associated hypertrophic cardiomyopathy: clinical application of a basic concept","volume":"40","author":"Chaput","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaccas.2026.107006_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1404253","article-title":"MEK inhibitors: a promising targeted therapy for cardiovascular disease","volume":"11","author":"Mohammed","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.jaccas.2026.107006_bib11","doi-asserted-by":"crossref","DOI":"10.2174\/011573403X341624250324164700","article-title":"RASopathies and cardiac complications: insights into mechanisms, diagnosis, and innovative treatments","volume":"21","author":"Garg","year":"2025","journal-title":"Curr Cardiol Rev"},{"issue":"9","key":"10.1016\/j.jaccas.2026.107006_bib12","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3390\/biomedicines11092337","article-title":"The role of extracellular signal-regulated kinase pathways in different models of cardiac hypertrophy in rats","volume":"11","author":"Moady","year":"2023","journal-title":"Biomedicines"},{"issue":"23","key":"10.1016\/j.jaccas.2026.107006_bib13","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jaccas.2026.107006_bib14","article-title":"The beneficial atrial septal defect shunt in hypertrophic cardiomyopathy\u2014When closure is not the answer","volume":"3","author":"Alnoor","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"11","key":"10.1016\/j.jaccas.2026.107006_bib15","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1017\/S1047951124036102","article-title":"Fenestrated closure of an atrial septal defect for left ventricular diastolic dysfunction in an early infant with hypertrophic cardiomyopathy","volume":"34","author":"Hayashi","year":"2024","journal-title":"Cardiol Young"},{"issue":"8","key":"10.1016\/j.jaccas.2026.107006_bib16","article-title":"RVOT stenting and Trametinib in an infant with Noonan syndrome, pulmonary stenosis, and hypertrophic cardiomyopathy","volume":"30","author":"Millette","year":"2025","journal-title":"JACC Case Rep"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926001518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926001518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:32:27Z","timestamp":1790249547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926001518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":16,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666084926001518"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.107006","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Septal Defect Surgical Closure Following Trametinib Utilization in Noonan Syndrome\u2013Associated Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.107006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"107006"}}